Avyxa Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVYXA HOLDINGS, and when can generic versions of AVYXA HOLDINGS drugs launch?
AVYXA HOLDINGS has two approved drugs.
There is one US patent protecting AVYXA HOLDINGS drugs.
There are seven patent family members on AVYXA HOLDINGS drugs in five countries and ten supplementary protection certificates in seven countries.
Summary for Avyxa Holdings
| International Patents: | 7 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Avyxa Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-002 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Avyxa Holdings | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 203050-002 | Mar 1, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-001 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Avyxa Holdings | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 203050-001 | Mar 1, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-003 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avyxa Holdings Drugs
Supplementary Protection Certificates for Avyxa Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0430190 | 18/2005 | Austria | ⤷ Sign Up | PRODUCT NAME: PALONOSETRON, DESSEN SALZE UND STEREOISOMERE; REGISTRATION NO/DATE: EU/1/04/306/001 20050322 |
| 2785706 | LUC00158 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
| 1035115 | 92745 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| 1667986 | 28/2013 | Austria | ⤷ Sign Up | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 0430190 | SPC/GB05/032 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322 |
| 2785706 | C02785706/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
